跳至主要内容
临床试验/CTRI/2024/11/076892
CTRI/2024/11/076892尚未招募2 期

A Single Arm Open Label Clinical Study To Evaluate The Efficacy Of Sarivadi Kwath Orally In Yonikandu

DrVaidehi Vasantrao Ayalwar1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年11月24日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
To determine the efficacy of Sarivadi Kwath orally On Yonikandu

研究概览

简要总结

The current study aimed as assessment of efficiency of Sarivadi Kwath Orally in Yonikandu.Total 50 diagnosed patient will be given the Sarivadi Kwath orally 40ml BD for 3 months .assesment will be done on subjective criteria of Yonikandu

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • Patint having symptoms of Yonikandu Controlled blood sugar level.

排除标准

  • Serologically positive patients Pregnant patients Patients suffering from auto immune disorder like SLE.

结局指标

主要结局

To determine the efficacy of Sarivadi Kwath orally On Yonikandu

时间窗: Assessment of Sarivadi Kwath orally on Yonikandu for 3 months

次要结局

  • To determine the efficacy of Sarivadi Kwath orally On Yonikandu(Assessment of Sarivadi Kwath Orally on Yonikandu for 4 week)

研究者

发起方
DrVaidehi Vasantrao Ayalwar
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

DrVaidehi Vasantrao Ayalwar

Ashtang Ayurved Mahavidyalaya Pune

研究点 (1)

Loading locations...

相似试验